Johnson Victor J, Burleson Stefanie C M, Luster Michael I, Burleson Gary R, McIntyre Barry, Robinson Veronica G, Fernando Reshan A, Blake James, Browning Donna, Cooper Stephen, Harris Shawn, Germolec Dori R
Burleson Research Technologies, Inc., Morrisville, NC 27560, USA.
Division of Translational Toxicology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27560, USA.
Toxics. 2025 Jul 17;13(7):600. doi: 10.3390/toxics13070600.
The broad-spectrum insect growth regulator (IGR) and insecticide 2-((1-(4-Phenoxyphenoxy)propan-2-yl)oxy)pyridine (MPEP; also known as pyriproxyfen) is increasingly being used to address public health programs for vector control, initiated by the spread of Zika virus in 2015-2016. While considered relatively safe for humans under normal conditions, limited toxicology data are available. Current studies were undertaken to address the data gap regarding potential immunotoxicity of MPEP, with particular emphasis on host resistance to viral infection. Hsd:Harlan Sprague Dawley SD rats were treated for 28 days by oral gavage with doses of 0, 62.5, 125, 250 or 500 mg/kg/day of MPEP in corn oil. There was a dose-dependent increase in liver weights which is consistent with the liver playing a dominant role in MPEP metabolism. However, no histological correlates were observed. Following treatment, rats were subjected to a battery of immune tests as well as an established rat model of influenza virus infection to provide a comprehensive assessment of immune function and host resistance. While several of the immune tests showed minor exposure-related changes, evidenced by negative dose-response trends, most did not show significant differences in any of the MPEP treatment groups relative to vehicle control. Most notable was a negative trend in pulmonary mononuclear cell phagocytosis with increases in dose of MPEP. There was also a positive trend in early humoral immune response (5 days after immunization) to keyhole limpet hemocyanin (KLH) as evidenced by increased serum anti-KLH IgM antibodies which was followed later (14 days following immunization) by decreasing trends in anti-KLH IgM and IgG antibody levels. However, MPEP treatment had no effect on the ability of rats to clear the influenza virus nor the T-dependent IgM and IgG antibody response to the virus. The lack of effects of MPEP on host resistance to influenza suggests the immune effects were minimal and unlikely to present a hazard with respect to susceptibility to respiratory viral infection.
广谱昆虫生长调节剂(IGR)及杀虫剂2-((1-(4-苯氧基苯氧基)丙-2-基)氧基)吡啶(MPEP;也称为吡丙醚)越来越多地被用于应对由2015 - 2016年寨卡病毒传播引发的病媒控制公共卫生项目。虽然在正常条件下被认为对人类相对安全,但可用的毒理学数据有限。开展了当前这些研究以填补关于MPEP潜在免疫毒性的数据空白,特别关注宿主对病毒感染的抵抗力。将Hsd:Harlan Sprague Dawley SD大鼠通过经口灌胃用玉米油中剂量为0、62.5、125、250或500 mg/kg/天的MPEP处理28天。肝脏重量呈剂量依赖性增加,这与肝脏在MPEP代谢中起主导作用一致。然而,未观察到组织学相关性。处理后,对大鼠进行一系列免疫测试以及一个既定的流感病毒感染大鼠模型,以全面评估免疫功能和宿主抵抗力。虽然一些免疫测试显示出与暴露相关的轻微变化,以负剂量反应趋势为证,但大多数MPEP处理组相对于赋形剂对照组在任何方面均未显示出显著差异。最值得注意的是随着MPEP剂量增加,肺单核细胞吞噬作用呈负趋势。对匙孔血蓝蛋白(KLH)的早期体液免疫反应(免疫后5天)也呈正趋势,血清抗KLH IgM抗体增加证明了这一点,随后(免疫后14天)抗KLH IgM和IgG抗体水平呈下降趋势。然而,MPEP处理对大鼠清除流感病毒的能力以及对该病毒的T细胞依赖性IgM和IgG抗体反应均无影响。MPEP对宿主抗流感能力缺乏影响表明免疫效应极小,不太可能对呼吸道病毒感染易感性构成危害。